Pmv Pharmaceuticals Stock Market Value
| PMVP Stock | USD 1.75 0.01 0.57% |
| Symbol | Pmv |
Pmv Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pmv Pharmaceuticals. If investors know Pmv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pmv Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.96) | Return On Assets (0.20) | Return On Equity (0.24) |
The market value of Pmv Pharmaceuticals is measured differently than its book value, which is the value of Pmv that is recorded on the company's balance sheet. Investors also form their own opinion of Pmv Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Pmv Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pmv Pharmaceuticals' market value can be influenced by many factors that don't directly affect Pmv Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pmv Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pmv Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pmv Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Pmv Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pmv Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pmv Pharmaceuticals.
| 11/17/2023 |
| 11/11/2024 |
If you would invest 0.00 in Pmv Pharmaceuticals on November 17, 2023 and sell it all today you would earn a total of 0.00 from holding Pmv Pharmaceuticals or generate 0.0% return on investment in Pmv Pharmaceuticals over 360 days. Pmv Pharmaceuticals is related to or competes with Unicycive Therapeutics, Hoth Therapeutics, and Instil Bio. PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and ... More
Pmv Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pmv Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pmv Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.34 | |||
| Information Ratio | 0.0502 | |||
| Maximum Drawdown | 13.98 | |||
| Value At Risk | (3.73) | |||
| Potential Upside | 6.21 |
Pmv Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pmv Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pmv Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Pmv Pharmaceuticals historical prices to predict the future Pmv Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.094 | |||
| Jensen Alpha | 0.2084 | |||
| Total Risk Alpha | (0.26) | |||
| Sortino Ratio | 0.0561 | |||
| Treynor Ratio | 0.565 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pmv Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pmv Pharmaceuticals Backtested Returns
Pmv Pharmaceuticals appears to be slightly risky, given 3 months investment horizon. Pmv Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.11, which implies the firm had a 0.11% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Pmv Pharmaceuticals, which you can use to evaluate the volatility of the company. Please evaluate Pmv Pharmaceuticals' Semi Deviation of 1.91, risk adjusted performance of 0.094, and Coefficient Of Variation of 873.21 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Pmv Pharmaceuticals holds a performance score of 8. The company holds a Beta of 0.51, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Pmv Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Pmv Pharmaceuticals is expected to be smaller as well. Please check Pmv Pharmaceuticals' sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to make a quick decision on whether Pmv Pharmaceuticals' historical price patterns will revert.
Auto-correlation | 0.43 |
Average predictability
Pmv Pharmaceuticals has average predictability. Overlapping area represents the amount of predictability between Pmv Pharmaceuticals time series from 17th of November 2023 to 15th of May 2024 and 15th of May 2024 to 11th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pmv Pharmaceuticals price movement. The serial correlation of 0.43 indicates that just about 43.0% of current Pmv Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.43 | |
| Spearman Rank Test | 0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Pmv Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Pmv Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pmv Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Pmv Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Pmv Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pmv Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pmv Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pmv Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pmv Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Pmv Pharmaceuticals Lagged Returns
When evaluating Pmv Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pmv Pharmaceuticals stock have on its future price. Pmv Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pmv Pharmaceuticals autocorrelation shows the relationship between Pmv Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Pmv Pharmaceuticals.
Regressed Prices |
| Timeline |
Pair Trading with Pmv Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pmv Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Pmv Stock
| 0.72 | ME | 23Andme Holding | PairCorr |
| 0.45 | A | Agilent Technologies Earnings Call Tomorrow | PairCorr |
| 0.37 | DRMA | Dermata Therapeutics | PairCorr |
The ability to find closely correlated positions to Pmv Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pmv Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pmv Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pmv Pharmaceuticals to buy it.
The correlation of Pmv Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pmv Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pmv Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pmv Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Pmv Stock Analysis
When running Pmv Pharmaceuticals' price analysis, check to measure Pmv Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv Pharmaceuticals is operating at the current time. Most of Pmv Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pmv Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pmv Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.